Viewing StudyNCT03080805



Ignite Creation Date: 2024-05-06 @ 9:50 AM
Last Modification Date: 2024-10-26 @ 12:20 PM
Study NCT ID: NCT03080805
Status: UNKNOWN
Last Update Posted: 2020-06-18
First Post: 2017-03-03

Brief Title: Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2 Metastatic Breast Cancer PHOEBE
Sponsor:
Organization: Jiangsu HengRui Medicine Co Ltd